We're transforming nature's medicine
Australia's first locally-cultivated producer
At Little Green Pharma, our primary focus is providing targeted and natural therapeutic solutions that transform the lives of patients. Everything we do as a company is geared towards achieving this result.
We put patients' needs first and aim to provide cannabinoid products that are consistent and cost effective.
Little Green Pharma works closely with medical practitioners to assist them with patient applications for medical cannabis products; saving time and money.
Clear market leader in Australia
We were the first medical cannabis company in Australia to produce locally-grown medical-grade cannabis oils.
Little Green Pharma is a responsive organisation that has a proven ability to quickly adapt and succeed in a dynamic, fast-moving Medicinal Cannabis market environment. We have speedily and successfully navigated the Australian regulatory system and have established strong relationships with key regulators and international partners.
High-quality Medicinal Cannabis products
We manufacture clean and naturally grown medicinal cannabis products for distribution within Australia and overseas. Our cannabis products are manufactured in accordance with GMP requirements and tested to stringent Australian quality standards.
Australia has some of the strictest cannabis growing and manufacturing regulations in the world imposed by key regulators, including the Office of Drug Control (ODC) and the Therapeutic Goods Administration (TGA). It is anticipated adherence to these standards will differentiate Australian cannabis products for international medical practitioners and patients.
Little Green Pharma is championing new product formulations intended to help improve patient treatment options and improve product affordability. These formulations are expected to have higher bioavailability, meaning a reduced dosage to achieve therapeutic effect and expected lower costs of production for the benefit of patients. Meanwhile, our patented formulation option to our existing product lines is intended help preserve the original cannabinoid profile, including the levels of cannabidiolic acid (CBDA) and non-intoxicating tetrahydrocannabinolic acid (THCA). Current research into these acidic-form cannabinoids shows promising antibacterial, anti-inflammatory and anti-nausea treatment properties.
Little Green Pharma's product packaging is made from recycled materials to remain eco-friendly certified and compliant with the Forest Stewardship Council (FSC) standards.
Unique market position
As an Australian producer, we are in a unique position to supply the European market with one of the few EU-recognised GMP manufacturing facilities globally. The European medicinal cannabis market is set to become the world’s largest legal medicinal cannabis market over the next five years.
Little Green Pharma will also leverage Australia’s network of free trade agreements (FTAs) to provide superior access to the fast-growing Asian region and other global opportunities.